COMMUNIQUÉS West-GlobeNewswire

HealthEquity Sets Date to Announce Second Quarter Results Fiscal Year 2020
13/08/2019
Attend Investor Conferences DRAPER, Utah, Aug. 13, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (HSA) custodian, [...]
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
13/08/2019
San Diego, CA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 13,000,000 shares of its common [...]
Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
13/08/2019
CeD LA 3001 trial doses first patient in historic Phase 3 celiac disease trial RALEIGH, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage [...]
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
13/08/2019
~ Richard S. Kollender Appointed to Chief Operating Officer ~ ~ Robert Lutz Promoted to Chief Financial Officer ~ ~ David Gill Appointed to Board of Directors ~ DUBLIN, Ireland and TREVOSE, Pa., Aug. 13, 2019 (GLOBE [...]
New IHIT Report Examines Hospital Cybersecurity Challenges and Identifies Next Steps in Protection
13/08/2019
How One Wrong Click Can Shut Down a Town ATLANTA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- The statistics are staggering – and frightening: healthcare data breaches are currently being reported at a rate of more than one a day [...]
Ultragenyx to Present at Wedbush PacGrow Healthcare Conference
13/08/2019
NOVATO, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Aura Announces Pharmadrug Operational & Investor Relations Update
13/08/2019
TORONTO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) (CSE:BUZZ, OTCQB:LMLLF ) is pleased to provide an operational update on Pharmadrug Production GmbH (the “ German Business ” or “ [...]
Novan’s Phase 3 Molluscum Pivotal Program Completes Enrollment
13/08/2019
MORRISVILLE, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has recently completed patient recruitment in the Company’s ongoing “B-SIMPLE” ( [...]
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
13/08/2019
63% of evaluable subjects whose tumors had progressed during prior checkpoint inhibitor therapy benefited from treatment with the combination of pepinemab and avelumab Primary completion anticipated in second half of [...]
Hamilton Thorne Announces the Acquisition of Planer Ltd.
13/08/2019
Significantly expands expertise and product offerings in incubation, cryo-preservation and lab monitoring Provides a direct sales and support platform for the entire Hamilton Thorne product portfolio in the UK BEVERLY, [...]
iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer
13/08/2019
iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer Gosselies, Belgium and Cambridge, MA – 13 August, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel [...]
AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4)
13/08/2019
WALTHAM, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase 14 [...]
Passage Bio Announces Launch of Natural History Study to Evaluate Patients with GM1 Gangliosidosis
13/08/2019
PHILADELPHIA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced the [...]
Syneos Health to Present at the 2019 Baird Global Healthcare Conference
13/08/2019
MORRISVILLE, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract [...]
Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
13/08/2019
On Track to Report Initial Clinical Data from Phase 1b Clinical Trial of RTX-134 for Phenylketonuria by Year-End CAMBRIDGE, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical- [...]
Inspire Medical Systems, Inc. Announces New Brand Identity and Website to Better Reach Prospective Patients Struggling with Sleep Apnea
13/08/2019
MINNEAPOLIS, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
LogicBio Reports Second Quarter 2019 Financial Results and Provides Business Updates
13/08/2019
CAMBRIDGE, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases in [...]
Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases
13/08/2019
City of Hope awarded California Institute for Regenerative Medicine grant to support ongoing Phase 1 clinical trial NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical- [...]
Establishment Labs Reports Second Quarter 2019 Financial Results
13/08/2019
NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]

Pages